ChIP-seq Ab Performance Comparison
Choosing an antibody that recognizes the correct target protein and does not show non-specific binding with other DNA-binding proteins is critical for a successful ChIP-seq experiment. CST now tests and validates recombinant rabbit monoclonal antibodies in ChIP-seq, because good performance in ChIP-qPCR does not necessarily mean an antibody will perform well for ChIP-seq, which requires more extensive capture of the target protein across a large number of gene loci. Our ChIP-seq approved antibodies are tested using the SimpleChIP Enzymatic Chromatin IP protocol followed by next-generation sequencing (NGS).
Advantages of using ChIP-seq antibodies produced at CST are:
- All ChIP-seq approved antibodies from CST are recombinant rabbit monoclonal antibodies, providing greater lot-to-lot reproducibility
- Antibodies are validated and optimized using the SimpleChIP Enzymatic Chromatin IP protocol, saving you time and money
- Antibodies are tested and validated for target specificity across multiple applications, providing reduced non-specific binding and high signal-to-noise ratio in ChIP-seq
- Antibodies are compatible with other ChIP-seq protocols, allowing for use in ChIP kits from CST or other suppliers, and in customized lab protocols
- Expert technical support is available from the same scientists who developed and validated the ChIP-seq antibodies
CST has compared many of our ChIP-seq antibodies to ChIP-seq approved antibodies from other companies. Click on any of the CST antibodies below to see how we perform against the competition.
- NEBNext is a registered trademark of New England Biolabs, Inc.
- Ultra is a trademark of New England Biolabs, Inc.
- Illumina is a registered trademark of Illumina, Inc.